CIK 0001158895 · Large accelerated filer
LEMAITRE VASCULAR INC
Sign in to watch- Ticker
- LMAT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 781-221-2266
- Business address
- 63 SECOND AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-30 | Kamke Trent G Senior V. P., Operations | Grant or award · Dividend Equivalent Rights | +0.89 | 10.64 | ||
| 2023-11-30 | Kamke Trent G Senior V. P., Operations | Grant or award · Dividend Equivalent Rights | +1.26 | 12.38 | ||
| 2023-11-30 | Kamke Trent G Senior V. P., Operations | Grant or award · Dividend Equivalent Rights | +2.35 | 19.93 | ||
| 2023-11-30 | Kamke Trent G Senior V. P., Operations | Grant or award · Dividend Equivalent Rights | +3.19 | 12.03 | ||
| 2023-11-30 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +1.5 | 35.55 | ||
| 2023-11-30 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +1.95 | 31.2 | ||
| 2023-11-30 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +2.74 | 29.92 | ||
| 2023-11-30 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +5.22 | 42.5 | ||
| 2023-11-30 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +7.09 | 26.74 | ||
| 2023-11-30 | Pellegrino Joseph P JR Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +1.5 | 35.55 | ||
| 2023-11-30 | Pellegrino Joseph P JR Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +1.95 | 31.19 | ||
| 2023-11-30 | Pellegrino Joseph P JR Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +2.74 | 29.92 | ||
| 2023-11-30 | Pellegrino Joseph P JR Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +5.22 | 42.5 | ||
| 2023-11-30 | Pellegrino Joseph P JR Chief Financial Officer | Grant or award · Dividend Equivalent Rights | +7.09 | 26.74 | ||
| 2023-11-27 | O'Connor John James Director | Option exercise | +7,500 | $23.56 | $177K | 56,454 |
| 2023-11-27 | O'Connor John James Director | Option exercise · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2023-11-20 | LeMaitre George W Chairman and CEO | Option exercise | +8,503 | $23.56 | $200K | 2,333,900 |
| 2023-11-20 | LeMaitre George W Chairman and CEO | Option exercise | +4,244 | $25.92 | $110K | 2,338,144 |
| 2023-11-20 | LeMaitre George W Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −8,503 | 4,244 | ||
| 2023-11-20 | LeMaitre George W Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −4,244 | 0 |
Page 63 of 66 · 1,303 trades